Syndax Pharmaceuticals share price logo

Syndax Pharmaceuticals Share Price

NASDAQ: SNDX

Small Cap

$14.76

-0.28

(-1.86%)

as on

Syndax Pharmaceuticals Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $14.67
    $15.36
    downward going graph

    0.61%

    Downside

    4.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.58
    $22.5
    downward going graph

    41.87%

    Downside

    52.44%

    Upside

    downward going graph

Syndax Pharmaceuticals share price movements today

Previous Close
$15.04
Open
$15.05
Volume
1.3M
Day's Low - High
$14.67 - $15.36
52 Week Low - High
$8.58 - $22.5

Syndax Pharmaceuticals Historical Returns

1 Month Return
-7.06 %
3 Month Return
+ 52.22 %
1 Year Return
-18.06 %
3 Year Return
-36.26 %
5 Year Return
-13.29 %

Syndax Pharmaceuticals Stock Fundamentals & Key Indicators

Check Syndax Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-3.1046

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-123.32

Industry PE ratio

-3.9415151515151514

P/B Ratio

0

PEG Ratio

0

EBITDA

-339.0M

Revenue (TTM)

77.9M

Profit Margin

0.00%

Return On Equity TTM

91224700.00%

Syndax Pharmaceuticals Stock Valuation

Track how Syndax Pharmaceuticals P/E has moved over time to understand its valuation trends.

Syndax Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (42.97x)

December 31, 2021

Today (-123.32x)

September 18, 2025

Industry (-3.94x)

September 18, 2025

Highest (104.05x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -123.32x

Syndax Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Syndax Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.3B-13.29%-123.320.00%
BUY$60.5B248.74%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Syndax Pharmaceuticals Stock including INR - Dollar returns

The Syndax Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Syndax Pharmaceuticals investment value today

Current value as on today

₹86,953

Returns

₹13,047

(-13.05%)

Returns from Syndax Pharmaceuticals Stock

₹18,000 (-18%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Syndax Pharmaceuticals Stock

Based on 19 analysts

BUY

89.47%

Buy

10.53%

Hold

0.00%

Sell

Based on 19 analysts, 89.47% of analysts recommend a 'BUY' rating for Syndax Pharmaceuticals. Average target price of $37.5

Syndax Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Syndax Pharmaceuticals.

What analysts predicted

60.64%UPSIDE

Target Price

$37.5

Current Price

$14.76

Analyzed by

19 Analysts

Target

$37.50

Syndax Pharmaceuticals target price $37.5, a slight upside of 60.64% compared to current price of $14.76. According to 19 analysts rating.

Syndax Pharmaceuticals Stock's Interest Amongst Investors

Search interest for Syndax Pharmaceuticals Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Syndax Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
-
3
12
7
20
37
Gross Profit
0
0
0
0
0
-40
12
6
19
36
Operating Income
-46
-49
-56
-77
-79
-74
-89
-96
-83
-69
EBITDA
-40
-44
-51
-72
-72
-68
-84
-89
-83
-63
Interest Expense
0
0
0
0
0
0
0
4
8
7
Depreciation
0
0
0
0
0
0
0
-
-
-
Income Before Tax
-41
-44
-51
-72
-72
-68
-84
-94
-84
-71
Income Tax Expense
-4
0
0
4
0
-
0
-
-
-
Net Income
-36
-44
-51
-72
-72
-68
-84
-94
-84
-71
Net Profit Margin
0.00%
0.00%
0.00%
-13521.08%
0.00%
-1944.66%
-673.01%
-1226.16%
-423.34%
-189.28%

Syndax Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
1
2
1
1
1
139
126
-
23
Gross Profit
0
1
2
1
1
1
139
0
0
22
Operating Income
-20
-43
-61
-75
-57
-71
26
-151
-229
-339
EBITDA
-20
-43
-61
-75
-57
-71
26
-151
-229
-313
Interest Expense
1
0
1
1
1
2
1
3
0
4
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-24
-44
-60
-73
-56
-73
24
-149
-209
-318
Income Tax Expense
1
0
0
1
0
0
0
-5
-
-318
Net Income
-24
-44
-60
-73
-55
-73
24
-143
-209
-318
Net Profit Margin
-3846.73%
-3645.25%
-2884.35%
-4875.48%
-3688.53%
-4816.68%
17.84%
-113.57%
0.00%
-1346.11%

Syndax Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-44
-51
-72
-72
-68
-84
-94
-84
-71
Operating Cash Flow
-35
-44
-41
-83
-71
-62
-57
-95
-87
Investing Cash Flow
73
40
-16
-99
61
86
-268
94
41
Financing Cash Flow
1
1
258
2
0
3
347
0
0
Change in Cash
39
-2
200
-180
-9
27
21
0
-45

Syndax Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-44
-60
-73
-56
-73
24
-149
-209
-318
Operating Cash Flow
-35
-47
-68
-50
-71
29
-133
-160
-274
Investing Cash Flow
-18
-17
51
12
-142
-40
-186
117
-219
Financing Cash Flow
54
75
15
28
304
118
172
264
353
Change in Cash
0
11
-1
-9
90
106
-147
221
-141

Global Institutional Holdings in Syndax Pharmaceuticals

Funds
Holdings
BlackRock Inc
9.93%
Kynam Capital Management, LP
9.9%
Vanguard Group Inc
5.66%
Eversept Partners, LLC
4.89%
Point72 Asset Management, L.P.
4.66%

Insights on Syndax Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 86.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 147.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SNDX stock has moved down by -9.9%

About Syndax Pharmaceuticals

syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451.
OrganisationSyndax Pharmaceuticals
Headquarters730 Third Avenue, New York, NY, United States, 10017
IndustryHealth Technology
CEOMr. Michael A. Metzger M.B.A.
E-voting on sharesClick here to vote

Key Management of Syndax Pharmaceuticals

Name

Title

Mr. Keith Alan Goldan CPA

CFO, Treasurer & Chief Accounting Officer

Dr. Michael Downes Ph.D.

Co-Founder

Sharon Klahre

Vice President of Investor Relations & Communications

Dr. Peter Ordentlich B.Sc., Ph.D.

Co-Founder & Chief Scientific Officer

Dr. Richard A. Heyman Ph.D.

Co-Founder

Dr. Ronald M. Evans Ph.D.

Co-Founder, Advisor and Chair of Scientific Advisory Board

Mr. Kevin McManus

Chief People Officer

Mr. Michael A. Metzger M.B.A.

CEO & Director

Mr. Luke J. Albrecht J.D.

Senior VP, General Counsel & Secretary

Mr. Steven Closter

Chief Commercial Officer

FAQs

What is Syndax Pharmaceuticals share price today?

Syndax Pharmaceuticals share price today is $14.76 as on at the close of the market. Syndax Pharmaceuticals share today touched a day high of $15.36 and a low of $14.67.

What is the 52 week high and 52 week low for Syndax Pharmaceuticals share?

Syndax Pharmaceuticals share touched a 52 week high of $22.5 on and a 52 week low of $8.58 on . Syndax Pharmaceuticals stock price today i.e. is closed at $14.76,which is 34.40% down from its 52 week high and 72.03% up from its 52 week low.

What is Syndax Pharmaceuticals's market capitalisation today?

Syndax Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Syndax Pharmaceuticals Stock (SNDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Syndax Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Syndax Pharmaceuticals Shares that will get you 0.1016 shares as per Syndax Pharmaceuticals share price of $14.76 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Syndax Pharmaceuticals Stock (SNDX) from India?

Indian investors can start investing in Syndax Pharmaceuticals (SNDX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Syndax Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Syndax Pharmaceuticals share’s latest price of $14.76 as on September 18, 2025 at 1:29 am IST, you will get 0.6775 shares of Syndax Pharmaceuticals. Learn more about fractional shares .

What are the returns that Syndax Pharmaceuticals has given to Indian investors in the last 5 years?

Syndax Pharmaceuticals stock has given -13.29% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?